Evidence map›Paper›PMID 36771036›Full record

ReviewMolecules (Basel, Switzerland)2023

Recent Developments in the Biological Activities, Bioproduction, and Applications of

Bruno Serafim, Ana R Bernardino, Filomena Freitas, Cristiana A V Torres

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Optimization of Pyocyanin Production byAntibiotics (Basel, Switzerland) · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Fast-growingbioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bruno SerafimLaboratory i4HB-Institute for Health and Bioeconomy, School of Science and Technology, NOVA University Lisbon, 2825-149 Caparica, Portugal.ORCID 0000-0002-7174-7203
Ana R BernardinoLaboratory i4HB-Institute for Health and Bioeconomy, School of Science and Technology, NOVA University Lisbon, 2825-149 Caparica, Portugal.
Filomena FreitasLaboratory i4HB-Institute for Health and Bioeconomy, School of Science and Technology, NOVA University Lisbon, 2825-149 Caparica, Portugal.ORCID 0000-0002-9430-4640
Cristiana A V TorresLaboratory i4HB-Institute for Health and Bioeconomy, School of Science and Technology, NOVA University Lisbon, 2825-149 Caparica, Portugal.

Funding

Applied Molecular Biosciences Unit - UCIBIO PTDC/CTM-CTM/29869/2017Applied Molecular Biosciences Unit - UCIBIO UIDP/04378/2020 and UIDB/04378/2020Associate Laboratory Institute for Health and Bioeconomy - i4HB LA/P/0140/2020Fundação para a Ciência e Tecnologia SFRH/BD/138011/2018
6 · The paper itself

Abstract

Phenazines are a large group of heterocyclic nitrogen-containing compounds with demonstrated insecticidal, antimicrobial, antiparasitic, and anticancer activities. These natural compounds are synthesized by several microorganisms originating from diverse habitats, including marine and terrestrial sources. The most well-studied producers belong to the

Indexed as

PhenazinesPseudomonasBiosynthetic PathwaysEcosystemPhenazinesbioprocessphenazinesPseudomonas spp.

Identifiers

PMID36771036
PMCPMC9919295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.